Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
34628 | 109 | 33.6 | 88% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
317 | 3 | HER2//TRASTUZUMAB//CHRONIC MYELOID LEUKEMIA | 39408 |
1648 | 2 | EPIDERMAL GROWTH FACTOR//HB EGF//TRANSFORMING GROWTH FACTOR ALPHA | 6893 |
34628 | 1 | EGF POLYMORPHISM//EPIDERMAL GROWTH FACTOR POLYMORPHISMS//CRYPTOMPHALUS ASPERSA | 109 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | EGF POLYMORPHISM | authKW | 1120573 | 4% | 100% | 4 |
2 | EPIDERMAL GROWTH FACTOR POLYMORPHISMS | authKW | 560286 | 2% | 100% | 2 |
3 | CRYPTOMPHALUS ASPERSA | authKW | 373523 | 2% | 67% | 2 |
4 | ANTIOBODIES | authKW | 280143 | 1% | 100% | 1 |
5 | C ASPERSA CELLULAR AND MOLECULAR EFFECTS | authKW | 280143 | 1% | 100% | 1 |
6 | CINTESISI MED | address | 280143 | 1% | 100% | 1 |
7 | CRCLM COLORECTAL CANCER LIVER METASTASES | authKW | 280143 | 1% | 100% | 1 |
8 | CUTANENOUS MELANOMA | authKW | 280143 | 1% | 100% | 1 |
9 | EGF 61A G | authKW | 280143 | 1% | 100% | 1 |
10 | EGF 61A G POLYMORPHISM | authKW | 280143 | 1% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 681 | 41% | 0% | 45 |
2 | Genetics & Heredity | 171 | 17% | 0% | 19 |
3 | Gastroenterology & Hepatology | 128 | 11% | 0% | 12 |
4 | Dermatology | 67 | 6% | 0% | 7 |
5 | Cell Biology | 22 | 9% | 0% | 10 |
6 | Integrative & Complementary Medicine | 21 | 2% | 0% | 2 |
7 | Medicine, Research & Experimental | 9 | 5% | 0% | 5 |
8 | Biotechnology & Applied Microbiology | 6 | 5% | 0% | 5 |
9 | Medicine, General & Internal | 4 | 5% | 0% | 5 |
10 | Respiratory System | 2 | 2% | 0% | 2 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CINTESISI MED | 280143 | 1% | 100% | 1 |
2 | EPE GRP ONCOL MOL CI | 280143 | 1% | 100% | 1 |
3 | INTERNAL MED OMORI MED | 280143 | 1% | 100% | 1 |
4 | MOL ONCOL GRP VIROL PATHOL | 280143 | 1% | 100% | 1 |
5 | OPHTHMAL | 280143 | 1% | 100% | 1 |
6 | PATHOLBARCELONA CLIN LIVER CANC GRP | 280143 | 1% | 100% | 1 |
7 | SURG TEACHING SECT | 280143 | 1% | 100% | 1 |
8 | TOKYO KAMATA MED | 280143 | 1% | 100% | 1 |
9 | U711 BIOL INTERACT NEURONES GLIE | 280143 | 1% | 100% | 1 |
10 | GRP ONCOL MOL | 140071 | 1% | 50% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | GENETIC TESTING AND MOLECULAR BIOMARKERS | 5875 | 5% | 0% | 5 |
2 | ANNALS OF GLOBAL HEALTH | 1999 | 1% | 1% | 1 |
3 | INTERNATIONAL NEUROUROLOGY JOURNAL | 1371 | 1% | 0% | 1 |
4 | INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS | 1244 | 2% | 0% | 2 |
5 | SKIN PHARMACOLOGY AND PHYSIOLOGY | 554 | 1% | 0% | 1 |
6 | PIGMENT CELL & MELANOMA RESEARCH | 485 | 1% | 0% | 1 |
7 | JOURNAL OF HUMAN GENETICS | 483 | 2% | 0% | 2 |
8 | ONCOLOGY LETTERS | 460 | 3% | 0% | 3 |
9 | DNA AND CELL BIOLOGY | 410 | 2% | 0% | 2 |
10 | CANCER GENETICS AND CYTOGENETICS | 409 | 3% | 0% | 3 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | LI, TF , REN, KW , LIU, PF , (2012) META-ANALYSIS OF EPIDERMAL GROWTH FACTOR POLYMORPHISMS AND CANCER RISK: INVOLVING 9,779 CASES AND 15,932 CONTROLS.DNA AND CELL BIOLOGY. VOL. 31. ISSUE 4. P. 568 -574 | 33 | 69% | 10 |
2 | XU, W , LI, Y , WANG, XL , CHEN, B , LIU, S , WANG, Y , ZHAO, WH , WU, JQ , (2010) ASSOCIATION BETWEEN EGF PROMOTER POLYMORPHISMS AND CANCER RISK: A META-ANALYSIS.MEDICAL ONCOLOGY. VOL. 27. ISSUE 4. P. 1389 -1397 | 30 | 68% | 14 |
3 | TAO, YQ , LIANG, GB , (2014) QUANTITATIVE ASSESSMENT OF THE ASSOCIATION BETWEEN +61A > G POLYMORPHISM OF EPIDERMAL GROWTH FACTOR GENE AND SUSCEPTIBILITY TO GLIOMA.TUMOR BIOLOGY. VOL. 35. ISSUE 1. P. 369 -377 | 20 | 63% | 3 |
4 | ZHANG, YM , CAO, C , LIANG, K , (2010) GENETIC POLYMORPHISM OF EPIDERMAL GROWTH FACTOR 61A > G AND CANCER RISK: A META-ANALYSIS.CANCER EPIDEMIOLOGY. VOL. 34. ISSUE 2. P. 150-156 | 20 | 54% | 22 |
5 | WANG, SJ , ZHAO, Y , RUAN, ZC , CHEN, HY , FAN, WW , CHEN, JX , WU, QH , QIAN, J , ZHANG, TB , HUANG, Y , ET AL (2010) ASSOCIATION BETWEEN EGF +61 G/A AND GLIOMA RISK IN A CHINESE POPULATION.BMC CANCER. VOL. 10. ISSUE . P. - | 22 | 48% | 13 |
6 | ZHANG, YY , ZHANG, J , SHEN, N , REN, KW , (2016) EGF RS4444903A ALLELE MAY DECREASE HEPATOCELLULAR CARCINOMA RISK IN CHINESE INDIVIDUALS: A META-ANALYSIS.INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE. VOL. 9. ISSUE 3. P. 5719 -5727 | 17 | 47% | 0 |
7 | CUI, L , PAN, XM , MA, CF , SHANG-GUAN, J , YU, HB , CHEN, GX , WANG, J , (2010) ASSOCIATION BETWEEN EPIDERMAL GROWTH FACTOR POLYMORPHISM AND ESOPHAGEAL SQUAMOUS CELL CARCINOMA SUSCEPTIBILITY.DIGESTIVE DISEASES AND SCIENCES. VOL. 55. ISSUE 1. P. 40-45 | 19 | 45% | 8 |
8 | PINTO, GR , YOSHIOKA, FKN , CLARA, CA , SANTOS, MJ , ALMEIDA, JRW , BURBANO, RR , REY, JA , CASARTELLI, C , (2009) ASSOCIATION STUDY OF AN EPIDERMAL GROWTH FACTOR GENE FUNCTIONAL POLYMORPHISM WITH THE RISK AND PROGNOSIS OF GLIOMAS IN BRAZIL.INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS. VOL. 24. ISSUE 4. P. 277-281 | 11 | 79% | 12 |
9 | SHEN, XF , ZENG, XT , JIAN, ZY , ZHOU, M , ZHOU, P , ZHANG, M , (2015) QUANTITATIVE ASSESSMENT OF THE EFFECT OF EPIDERMAL GROWTH FACTOR 61A/G POLYMORPHISM ON THE RISK OF HEPATOCELLULAR CARCINOMA.ONCOLOGY LETTERS. VOL. 10. ISSUE 5. P. 3199 -3205 | 15 | 50% | 1 |
10 | SUENAGA, M , YAMADA, S , FUJII, T , FUCHS, BC , OKUMURA, N , KANDA, M , KOBAYASHI, D , TANAKA, C , NAKAYAMA, G , SUGIMOTO, H , ET AL (2013) A FUNCTIONAL POLYMORPHISM IN THE EPIDERMAL GROWTH FACTOR GENE PREDICTS HEPATOCELLULAR CARCINOMA RISK IN JAPANESE HEPATITIS C PATIENTS.ONCOTARGETS AND THERAPY. VOL. 6. ISSUE . P. 1805-1812 | 15 | 47% | 4 |
Classes with closest relation at Level 1 |